Early Impact of Dupilumab in Disease Severity and Quality of Life of Patients Affected by Moderate-to-severe Atopic Dermatitis: A Prospective Study G.G. Garriga-Martina, J.A. Suárez-Pérez, E.A. Martínez-García, E. Herrera-Acosta

RF – OX40: A Promising Therapeutic Target in Moderate-to-severe Atopic Dermatitis M. Zulaika-Lloret, M. Rodriguez-Troncoso, R. Ruiz-Villaverde

RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure? M.A. Lasheras-Pérez, F. Navarro-Blanco, M. Rodríguez-Serna